Eli Lilly at PepTalk 2027

Jan 18–21, 2027 Carlsbad, CA ~1k attendees Website

Eli Lilly brings 5 presentations to PepTalk 2027 in Carlsbad. Its sessions weigh how AI and shared data are changing biologic and peptide drug discovery. It also covers predictive accelerated stability studies for oligonucleotide therapeutics and how to pick a multispecific antibody design from discovery to development.

OrganizationPepTalk 2027 Attendance
Eli Lilly
Indianapolis, IN
Large pharma
Global pharmaceutical company with peptide, antibody and other medicines in diabetes, obesity, oncology, immunology and neuroscience.
Panel
Tue Jan 19
11:50am–12:20pm
Selecting the Optimal Multispecific Format: Engineering Strategies from Discovery to Development
Multispecifics Engineering & Design · with Rondo Therapeutics, AstraZeneca, Xencor +2 more
Panel
Tue Jan 19
4:55pm–5:25pm
AI's Real Impact on Biologic Drug Discovery: The Honest Scorecard
Plenary · with Novo Nordisk, Prescient Design, Generate Biomedicines
Predictive and AI-driven protein science
Panel
Wed Jan 20
1:20pm–2:15pm
Peptides at the Inflection Point: From Constrained Scaffolds to AI-Designed Clinical Candidates—Where is Peptide Therapeutics Headed?
Plenary · with EPOC Scientific, Unnatural Products, Novo Nordisk +2 more
Peptide discovery and developmentPredictive and AI-driven protein science
Talk
Wed Jan 20
5:40pm–6:10pm

Explore the full PepTalk 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Carlsbad. Leave your work email and we’ll be in touch.

Privacy

Download the full PepTalk 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Eli Lilly

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by PepTalk or its organizers. Submit a correction